Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind Study to Assess Safety, Immunogenicity, and Lot Consistency of Solvay's Cell-Derived Influenza Vaccine and Its Non-Inferiority Compared to Influvac®.

NCT00999206 is registered in ClinicalTrials.gov with Abbott Biologicals as lead sponsor.

NCT NCT00999206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00999206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind Study to Assess Safety, Immunogenicity, and Lot Consistency of Solvay's Cell-Derived Influenza Vaccine and Its Non-Inferiority Compared to Influvac®.
Lead sponsor
Abbott Biologicals
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2010
Enrollment
3,138 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

influenza